Pharmacokinetic and cell-biological investigation of prednimustine compared to its components chlorambucil and prednisolone.
Musch
E
E
Department of Internal Medicine, Institute of Clinical Biochemistry, and Institute of Oncological Chemistry, Universities of Bonn and Düsseldorf, FRG.
Loos
U
U
Alléra
A
A
Hügl
E
E
Pütz
I
I
Malek
M
M
D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D045744:Cell Line, Tumor; D002699:Chlorambucil / Q000493:pharmacokinetics* / Q000494:pharmacology; D006224:Cricetinae; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood; D008214:Lymphocytes / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D011238:Prednimustine / Q000493:pharmacokinetics* / Q000494:pharmacology*; D011239:Prednisolone / Q000493:pharmacokinetics* / Q000494:pharmacology; D051381:Rats
D002699:Chlorambucil; D011238:Prednimustine; D011239:Prednisolone